Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible staphylococcus aureus bacteraemia: A retrospective, propensity-score-adjusted case-control and cohort analysis

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 8, 2013, Pages 1894-1900

  Nissen, Jette Lindbjerg ^a,b   Skov, Robert ^a   Knudsen, Jenny Dahl ^a   Østergaard, Christian ^b   Schønheyder, Henrik Carl ^c   Frimodt MØller, Niels ^b   Benfield, Thomas ^b,d  

^a STATENS SERUM INSTITUT   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Epidemiology; Sepsis; Survival analysis

Indexed keywords

CEFUROXIME; DICLOXACILLIN; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PENICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA; RETROSPECTIVE STUDY; STAPHYLOCOCCAL BACTEREMIA;

EPIDEMIOLOGY; SEPSIS; SURVIVAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; CEFUROXIME; COHORT STUDIES; DENMARK; DICLOXACILLIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLINS; PROPENSITY SCORE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880709714     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt108     Document Type: Article

References (17)

1. Statens Serum Institut. Annual Report on Staphylococcus aureus Bacteraemia Cases in Denmark 2009 (Part I). http://www.ssi.dk/Forskning/Forskningsomraader/Infektioner/Systemiske%20infektioner/~/media/Indhold/DK%20-%20dansk/Forskning/Infektioner/SAB%202009%20part%20I%20final.ashx (16 March 2013, date last accessed).
2. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf (16 March 2013, date last accessed).
3. Paul M, Zemer-Wassercug N, Talker O et al. Are all b-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 2011; 17: 1581-6.
4. Schweizer ML, Furuno JP, Harris AD et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011; 11: 279.
5. Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics 1996; 52: 249-64.
6. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-81.
7. Garner JS, Jarvis WR, Emori TG et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
8. Friedman ND, Kaye KS, Stout JE et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
9. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999; 11: 7-12.
10. Hill PC, Birch M, Chambers S et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001; 31: 97-103.
11. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39: 30-3.
12. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
13. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982; 115: 92-106.
14. Nannini EC, Stryjewski ME, Singh KV et al. Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54: 2206-8.
15. Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and b-lactam resistance. FEMS Microbiol Rev 2008; 32: 361-85.
16. Dagan R, Klugman KP, Craig WA et al. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother 2001; 47: 129-40.
17. Chambers HF. Penicillins and b-lactam inhibitors. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th edn. Philadelphia, PA: Churchill Livingstone Elsevier, 2010; 309-22.